MedPath

Succinylcholine

Generic Name
Succinylcholine
Brand Names
Anectine, Quelicin
Drug Type
Small Molecule
Chemical Formula
C14H30N2O4
CAS Number
306-40-1
Unique Ingredient Identifier
J2R869A8YF
Background

Succinylcholine is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter acetylcholine (ACh) linked by their acetyl groups. It has been widely used for over 50 years, most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation.

Indication

Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

Associated Conditions
-
Associated Therapies
Tracheal Intubation

Rapid Sequence Intubation With Rocuronium-Sugammadex Compared With Succinylcholine

Phase 4
Completed
Conditions
Rapid Sequence Intubation
Interventions
Drug: Rocuronium-Sugammadex
Drug: Succinylcholine
First Posted Date
2009-08-06
Last Posted Date
2011-03-02
Lead Sponsor
Rigshospitalet, Denmark
Target Recruit Count
61
Registration Number
NCT00953550
Locations
🇩🇰

Rigshospitalet, Copenhagen, Denmark

🇩🇰

Herlev Hospital, Herlev, Denmark

Rocuronium Plus Sugammadex Versus Succinylcholine Alone in Participants Undergoing Short Surgical Procedures (19.4.319)(P05700 AM2)(COMPLETED)

Phase 3
Completed
Conditions
Neuromuscular Blockade
Interventions
First Posted Date
2008-09-11
Last Posted Date
2015-06-30
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
161
Registration Number
NCT00751179

Comparison of Recovery From Rocuronium 1.2 mg/kg Followed by Sugammadex (Org 25969) 16 mg/kg at 3 Minutes With Recovery From Succinylcholine 1.0 mg/kg (19.4.303)(P05946)(MK-8616-026)

Phase 3
Completed
Conditions
Anesthesia, General
Interventions
First Posted Date
2007-05-16
Last Posted Date
2019-04-11
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
115
Registration Number
NCT00474253

Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care

Phase 4
Completed
Conditions
Intubation
Interventions
First Posted Date
2006-07-21
Last Posted Date
2011-12-15
Lead Sponsor
University Hospital, Basel, Switzerland
Target Recruit Count
420
Registration Number
NCT00355368
Locations
🇨🇭

Department of Medical Intensive Care; University of Basel, Basel, BS, Switzerland

© Copyright 2025. All Rights Reserved by MedPath